Home/Filings/4/0001415889-25-010234
4//SEC Filing

Rosner Elimelech 4

Accession 0001415889-25-010234

CIK 0001428336other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:30 PM ET

Size

9.1 KB

Accession

0001415889-25-010234

Insider Transaction Report

Form 4
Period: 2025-04-02
Rosner Elimelech
EVP, CHIEF TECHNOLOGY OFFICER
Transactions
  • Award

    Common Stock

    2025-04-02+16,90372,391 total
  • Award

    Common Stock

    2025-04-02+117,176189,567 total
  • Tax Payment

    Common Stock

    2025-04-03$83.88/sh3,800$318,727185,767 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2026. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2026.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 117,176 shares on April 2, 2025.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.8740 to $83.8782 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) of this Form 4.

Issuer

HEALTHEQUITY, INC.

CIK 0001428336

Entity typeother

Related Parties

1
  • filerCIK 0001916312

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:30 PM ET
Size
9.1 KB